In The News,
“Government Negotiation” of Drug Prices
Developed binding arbitration scenarios that could be implemented as part of a future “government negotiation” policy reform for prescription drugs. Analyzed past and current use of binding arbitration in the health care and non-health care settings, with a specific focus on the prescription drug model adopted by Germany. Provided mi